Visualizing the Future: Advances in IL-23-Targeted Therapies in the Treatment of IBD

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.

 

Location

May 19, 2024
6:30pm – 8pm ET

The Capital Hilton Hotel
Room: Congressional/Senate
1001 16th St NW, Washington, DC 20036